Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment

Inclusion Criteria: * Participants in Groups B and C will be classified by renal function by eGRF at screening and confirmed on Day -1 * Participants in Group A will be healthy participants as determined by no significant deviations in normal medical and surgical history and assessments * Participants in Group A must have a body mass index of 18.0 to 32.0 kg/m2, inclusive * Females must be of non-childbearing potential Exclusion Criteria: * Participants in Groups B and C cannot have an indwelling catheter for hemodialysis * Participants in Groups B and C cannot have had, nor be waiting for, an organ transplant Other protocol defined inclusion and exclusion criteria could apply